Daré Bioscience, Inc.
Clinical trials sponsored by Daré Bioscience, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a monthly ring replace the pill? new study tests Hormone-Free contraceptive Results expected Apr 2027 (estimated)
-
Could a vaginal capsule wipe out persistent HPV?
Disease control Recruiting nowThis study tests whether DARE-HPV, a vaginal capsule containing HIV drugs lopinavir and ritonavir, can clear persistent high-risk HPV infections in women aged 22-50. Participants will receive one of two doses for 14 or 21 days, or a placebo. The main goal is to see if the infecti…
Phase 2 • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a monthly ring replace the pill? new study tests Hormone-Free contraceptive
Disease control Recruiting nowThis study is testing Ovaprene, a non-hormonal vaginal ring worn for a month at a time to prevent pregnancy. About 656 women aged 18–40 will use the ring for up to 13 menstrual cycles. Researchers will track how many become pregnant and how safe and acceptable the ring is.
Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC